Automated and Closed Cell Therapy Market Research 2024-2029 Featuring Leading Players - Danaher, Thermo Fischer Scientific, Lonza, and Sartorius
24 sept. 2024 09h22 HE
|
Research and Markets
Dublin, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Automated and Closed Cell Therapy Market 2024-2029" report has been added to ResearchAndMarkets.com's offering. In 2023, the global market...
Consumer Healthcare Market Size is Projected to Reach USD 575.40 Billion by 2032, Growing at a CAGR of 7.51%: Straits Research
24 sept. 2024 09h10 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, Sept. 24, 2024 (GLOBE NEWSWIRE) -- As per the Latest Report by Straits Research, The global consumer healthcare market size was valued at USD 303.37 billion in 2023 and is...
Life Sciences Week 2024: Advancing Innovation, Investment, and Collaboration in Alberta’s Life Sciences Sector
23 sept. 2024 13h10 HE
|
Applied Pharmaceutical Innovation (API)
Life Sciences Week, Alberta’s flagship event for showcasing the life sciences sector returns from September 23 to 27, 2024.
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366
23 sept. 2024 08h00 HE
|
Assembly Biosciences, Inc.
– ABI-5366 was well-tolerated, with a favorable safety profile observed with exposure of up to 70 days – – Half-life of approximately 20 days supports once-weekly or once-monthly oral dosing; both...
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement
23 sept. 2024 08h00 HE
|
European Microbiome Innovation for Health
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement Paris, France, September 23, 2024, 2:00 pm CET - The European Microbiome...
BioSyent Announces Agreement to Purchase Tibelia® (tibolone) Assets
20 sept. 2024 09h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Sept. 20, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc., has...
UAE Pharmaceuticals Market, By Region, Competition, Forecast and Opportunities, 2029F
20 sept. 2024 04h53 HE
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "UAE Pharmaceuticals Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's...
Western Blotting Market Is Expected To Generate Revenue Of USD 2,620.2 Mn By 2033, At 6.8% CAGR: Dimension Market Research.
18 sept. 2024 12h15 HE
|
Dimension Market Research
New York, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Overview The Global Western Blotting Market is expected to reach USD 1,455.4 million in 2024 which is further projected to grow up to USD 2,620.2...
[Latest] Global Sanitary Pumps and Valves Market Size/Share Worth USD 3.1 Billion by 2033 at a 3.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
17 sept. 2024 13h00 HE
|
Custom Market Insights
Austin, TX, USA, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Sanitary Pumps and Valves Market Size, Trends and Insights By Type...
Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Treatment of Moderate to Severe Atopic Dermatitis
17 sept. 2024 07h00 HE
|
Aclaris Therapeutics, Inc.
Aclaris Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor for the Trea